-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on DarioHealth, Lowers Price Target to $2

Benzinga·03/11/2025 12:43:54
Listen to the news
Stifel analyst David Grossman maintains DarioHealth (NASDAQ:DRIO) with a Buy and lowers the price target from $3.5 to $2.